These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28571670)

  • 1. Accuracy and Interobserver Variability in Reporting of PI-RADS Version 2.
    Flood TF; Pokharel SS; Patel NU; Clark TJ
    J Am Coll Radiol; 2017 Sep; 14(9):1202-1205. PubMed ID: 28571670
    [No Abstract]   [Full Text] [Related]  

  • 2. Interobserver Reproducibility of the PI-RADS Version 2 Lexicon: A Multicenter Study of Six Experienced Prostate Radiologists.
    Rosenkrantz AB; Ginocchio LA; Cornfeld D; Froemming AT; Gupta RT; Turkbey B; Westphalen AC; Babb JS; Margolis DJ
    Radiology; 2016 Sep; 280(3):793-804. PubMed ID: 27035179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer.
    Matsuoka Y; Ishioka J; Tanaka H; Kimura T; Yoshida S; Saito K; Fujii Y; Kihara K
    AJR Am J Roentgenol; 2017 Aug; 209(2):W76-W84. PubMed ID: 28570124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and Interobserver Agreement for Prostate Imaging Reporting and Data System, Version 2, for the Characterization of Lesions Identified on Multiparametric MRI of the Prostate.
    Purysko AS; Bittencourt LK; Bullen JA; Mostardeiro TR; Herts BR; Klein EA
    AJR Am J Roentgenol; 2017 Aug; 209(2):339-349. PubMed ID: 28570099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of PI-RADS v2 for the Detection of Prostate Cancer.
    Kasel-Seibert M; Lehmann T; Aschenbach R; Guettler FV; Abubrig M; Grimm MO; Teichgraeber U; Franiel T
    Eur J Radiol; 2016 Apr; 85(4):726-31. PubMed ID: 26971415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer.
    Cao Y; Cao M; Chen Y; Yu W; Fan Y; Liu Q; Gao G; Zhao Z; Wang X; Jin J
    Oncotarget; 2017 Jul; 8(27):44040-44049. PubMed ID: 28476042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical primer on PI-RADS version 2: a pictorial essay.
    Horn GL; Hahn PF; Tabatabaei S; Harisinghani M
    Abdom Radiol (NY); 2016 May; 41(5):899-906. PubMed ID: 26984751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
    Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
    BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.
    Muller BG; Shih JH; Sankineni S; Marko J; Rais-Bahrami S; George AK; de la Rosette JJ; Merino MJ; Wood BJ; Pinto P; Choyke PL; Turkbey B
    Radiology; 2015 Dec; 277(3):741-50. PubMed ID: 26098458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary regarding the inter-reader reproducibility of PI-RADS version 2.
    Rosenkrantz AB; Margolis DJ
    Abdom Radiol (NY); 2016 May; 41(5):907-9. PubMed ID: 27138435
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
    Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI-RADS Version 2: Detection of Clinically Significant Cancer in Patients With Biopsy Gleason Score 6 Prostate Cancer.
    Seo JW; Shin SJ; Taik Oh Y; Jung DC; Cho NH; Choi YD; Park SY
    AJR Am J Roentgenol; 2017 Jul; 209(1):W1-W9. PubMed ID: 28418690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interreader Agreement of Prostate Imaging Reporting and Data System Version 2 Using an In-Bore MRI-Guided Prostate Biopsy Cohort: A Single Institution's Initial Experience.
    Glazer DI; Mayo-Smith WW; Sainani NI; Sadow CA; Vangel MG; Tempany CM; Dunne RM
    AJR Am J Roentgenol; 2017 Sep; 209(3):W145-W151. PubMed ID: 28657843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice Patterns and Challenges of Performing and Interpreting Prostate MRI: A Survey by the Society of Abdominal Radiology Prostate Disease-Focused Panel.
    Chang SD; Margolis DJA; Turkbey B; Arnold AA; Verma S
    AJR Am J Roentgenol; 2021 Apr; 216(4):952-959. PubMed ID: 33566638
    [No Abstract]   [Full Text] [Related]  

  • 15. Focal cystic pancreatic lesions: variability in radiologists' recommendations for follow-up imaging.
    Macari M; Megibow AJ
    Radiology; 2011 Apr; 259(1):20-3. PubMed ID: 21436094
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of Prostate Imaging Reporting and Data System Version 2 Using an MRI-Ultrasound Fusion Biopsy in Prostate Cancer Diagnosis.
    Kim SH; Choi MS; Kim MJ; Kim YH; Cho SH
    AJR Am J Roentgenol; 2017 Oct; 209(4):800-805. PubMed ID: 28705064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesion volume predicts prostate cancer risk and aggressiveness: validation of its value alone and matched with prostate imaging reporting and data system score.
    Martorana E; Pirola GM; Scialpi M; Micali S; Iseppi A; Bonetti LR; Kaleci S; Torricelli P; Bianchi G
    BJU Int; 2017 Jul; 120(1):92-103. PubMed ID: 27608292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implications of PI-RADS Version 1 and Updated Version 2 on the Scoring of Prostatic Lesions in Multiparametric MRI].
    Haas M; Günzel K; Penzkofer T; Maxeiner A; Fischer T; Miller K; Hamm B; Asbach P; Cash H
    Aktuelle Urol; 2016 Sep; 47(5):383-7. PubMed ID: 27680189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prostate cancer gene 3 (PCA3) scores are associated with elevated Prostate Imaging Reporting and Data System (PI-RADS) grade and biopsy Gleason score, at magnetic resonance imaging/ultrasonography fusion software-based targeted prostate biopsy after a previous negative standard biopsy.
    De Luca S; Passera R; Cattaneo G; Manfredi M; Mele F; Fiori C; Bollito E; Cirillo S; Porpiglia F
    BJU Int; 2016 Nov; 118(5):723-730. PubMed ID: 27112799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Androgen Deprivation Therapy With Radiotherapy for Intermediate- and High-Risk Prostate Cancer Across the United States.
    Falchook AD; Basak R; Mohiuddin JJ; Chen RC
    JAMA Oncol; 2016 Sep; 2(9):1236-8. PubMed ID: 27367418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.